Pharmabiz

TempraMed Technologies expands US manufacturing capacity with new production facility in Florida

TempraMed Technologies Ltd, a medical technology innovator transforming how temperature-sensitive medications are stored and managed, announced that it has opened an additional United States ...
Pharmabiz

Zydus Lifesciences inks exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India

Zydus Lifesciences inks exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India: Friday, December 19, 2025, 12:45 Hrs [IST] Zydus ...
Pharmabiz

Telangana DCA raids 63 medical shops in state-wide crackdown

Our Bureau, Chennai Friday, December 19, 2025, 12:30 Hrs [IST] The Drugs Control Administration (DCA) of Telangana la ...
Pharmabiz

iLive Connect launches ‘Doctor-Led Continuous Care platform, to aid healthcare beyond hospital

Led Continuous Care platform, to aid healthcare beyond hospital: Our Bureau, Bengaluru Friday, December 19, 2025, 12:15 Hrs [IST] iLive Connect, a ...
Pharmabiz

UK MHRA updates guidance on the Health Institution Exemption to support safe use of medical devices

UK MHRA updates guidance on the Health Institution Exemption to support safe use of medical devices: United Kingdom Friday, December 19, 2025, 12:00 Hrs [IST] Patients across Engl ...
Pharmabiz

Lifecore Biomedical inks CDMO services agreement with global multinational pharmaceutical customer

Lifecore Biomedical inks CDMO services agreement with global multinational pharmaceutical customer: Chaska, Minnesota Friday, December 19, 2025, 11:00 Hrs [IST] Lifecore Biomedica ...
Pharmabiz

Astellas Pharma announces positive topline results from phase 3 EV-304 clinical trial of Padcev plus Keytruda

Astellas Pharma announces positive topline results from phase 3 EV-304 clinical trial of Padcev plus Keytruda: Tokyo Friday, December 19, 2025, 10:00 Hrs [IST] Astellas Pharma Inc ...
Pharmabiz

EMA validates Type II Variation marketing authorization application of Datroway as first-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy

EMA validates Type II Variation marketing authorization application of Datroway as first-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy ...
Pharmabiz

IPC 2025 to bolster Bengaluru’s global stand as hub for CRAMS and GCCs, fuelled by quality talent

IPC 2025 to bolster Bengaluru’s global stand as hub for CRAMS and GCCs, fuelled by quality talent: Nandita Vijayasimha, Bengaluru Friday, December 19, 2025, 08:00 Hrs [IST] Indi ...
Pharmabiz

PDMA urges govt to allow 2 more years to smaller units to comply with revised Schedule M

PDMA urges govt to allow 2 more years to smaller units to comply with revised Schedule M: Gireesh Babu, New Delhi Friday, December 19, 2025, 08:00 Hrs [IST] With less than a fortn ...
Opinion
PharmabizOpinion

Union govt must fortify regulatory frameworks to strengthen trust in Indian medicines: Dr Jagashetty

Union govt must fortify regulatory frameworks to strengthen trust in Indian medicines: Dr Jagashetty: Nandita Vijayasimha, Bengaluru Friday, December 19, 2025, 08:00 Hrs [IST] The ...
Pharmabiz

APDCA warns drugs inspectors of strict action if they interfere in pharmacy council elections

APDCA warns drugs inspectors of strict action if they interfere in pharmacy council elections: Peethaambaran Kunnathoor, Chennai Friday, December 19, 2025, 08:00 Hrs [IST] The And ...